The Role of Tenascin in Neointimal Formation

腱蛋白在新内膜形成中的作用

基本信息

  • 批准号:
    7406759
  • 负责人:
  • 金额:
    $ 37.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-06-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Previous investigations by us and others have used a cell culture system to establish the vascular function of TN. We have now extended these observations in vivo to test the hypothesis that the genetic deletion of TN in the apo E-/- background might modify neointimal hyperplasia in an injured artery, and in atherosclerotic lesions. TN/E-mice developed atherosclerotic lesions one-week after being fed on a high fat diet. This lesion development was more rapid and more complex than was observed with Apo E mice. Concomitantly, VCAM- 1 expression was detected in the TN/E group alone. FACS analysis revealed that the VCAM-1 expression level in TN/E-derived endothelial cells was markedly higher than that from apo E mice. Finally, TN was found to down-regulate VCAM-1 promoter activity when induced by TNF-a in endothelial cells. These data suggest that TN deficiency promotes leukocyte/endothelial cell interaction. In addition to the rapid development of plaque, chronic hyperlipidemia in TN/E mice resulted in the formation of unstable plaques. The antibody array and ELISA analyses of chronic hyperlipidemic plasma from the two mouse genotypes showed that eotaxin, a CC chemokine, is selectively upregulated by 4- to 5-fold in the TN/E groups when compared to apo E mice. Furthermore, there was an accumulation of mast cells in the adventitia of unstable lesions in TN/E group. Collectively, our data point to an anti-inflammatory role for TN in vascular diseases. The overall goal of this proposal is to test 4 specific hypotheses (Aims). - Aim 1. A specific domain/segment of TN negatively regulates TNF-a induced VCAM-1 promoter activity. Aim 2. Chronic hyperlipidemia in TN/E mice up-regulates eotaxin promoting an accumulation of mast cells. Aim 3. TN deficiency promotes neointimal formation after vascular injury. Aim 4. TN deficiency per se is sufficient for neointimal formation.
描述(由申请人提供):我们和其他人以前的研究使用细胞培养系统来建立TN的血管功能。我们现在已经在体内扩展了这些观察结果,以检验载脂蛋白E-/-背景中TN的基因缺失可能改变损伤动脉和动脉粥样硬化病变中的新生内膜增生的假设。TN/E-小鼠在喂食高脂肪饮食一周后发生动脉粥样硬化病变。这种病变发展比在Apo E小鼠中观察到的病变发展更快、更复杂。同时,在单独的TN/E组中检测到VCAM- 1表达。流式细胞仪分析显示TN/E来源的内皮细胞VCAM-1表达水平明显高于apo E小鼠。最后,发现当内皮细胞中TNF-a诱导时,TN下调VCAM-1启动子活性。这些数据表明,TN缺乏促进白细胞/内皮细胞的相互作用。除了斑块的快速发展外,TN/E小鼠的慢性高脂血症导致不稳定斑块的形成。来自两种小鼠基因型的慢性高脂血症血浆的抗体阵列和ELISA分析表明,与apo E小鼠相比,TN/E组中的嗜酸性粒细胞趋化因子(一种CC趋化因子)选择性上调4至5倍。TN/E组不稳定病灶外膜有肥大细胞聚集。总的来说,我们的数据表明TN在血管疾病中具有抗炎作用。本提案的总体目标是测试4个特定假设(目标)。- 目标1. TN的特定结构域/片段负调控TNF-α诱导的VCAM-1启动子活性。目标二。TN/E小鼠慢性高脂血症上调嗜酸性粒细胞趋化因子,促进肥大细胞的积累。目标3. TN缺乏促进血管损伤后新生内膜形成。目标4。TN缺乏本身足以形成新生内膜。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Prediman Krishan Shah其他文献

Management of Aminotransferase Elevations Observed in a Phase 3 Study of Patients with Homozygous Familial Hypercholesterolemia Treated with Lomitapide
  • DOI:
    10.1016/j.jacl.2013.03.058
  • 发表时间:
    2013-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marina Cuchel;Emma A. Meagher;Prediman Krishan Shah;LeAnne T. Bloedon;Daniel J. Rader; Phase 3 HoFH Lomitapide Study Investigators
  • 通讯作者:
    Phase 3 HoFH Lomitapide Study Investigators
Multiple myocardial crypts on cardiac CT angiography in a symptomatic patient with troponin elevation
  • DOI:
    10.1016/j.ijcard.2011.01.020
  • 发表时间:
    2011-11-17
  • 期刊:
  • 影响因子:
  • 作者:
    Rine Nakanishi;Ronak Rajani;Haim Shmilovich;Prediman Krishan Shah;Daniel S. Berman
  • 通讯作者:
    Daniel S. Berman
Apheresis Treatment did not Impact the Efficacy of Lomitapide in Patients with Homozygous Familial Hypercholesterolemia: Results from the Pivotal Phase†
  • DOI:
    10.1016/j.jacl.2013.03.095
  • 发表时间:
    2013-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marina Cuchel;Emma A. Meagher;Prediman Krishan Shah;LeAnne T. Bloedon;Daniel J. Rader; Phase 3 HoFH Lomitapide Study Investigators
  • 通讯作者:
    Phase 3 HoFH Lomitapide Study Investigators

Prediman Krishan Shah的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Prediman Krishan Shah', 18)}}的其他基金

The role of GATA3-positive macrophages in cardiovascular pathologies
GATA3 阳性巨噬细胞在心血管病理中的作用
  • 批准号:
    10643888
  • 财政年份:
    2022
  • 资助金额:
    $ 37.87万
  • 项目类别:
A hypercholesterolemia-induced immunometabolite in atherosclerosis
高胆固醇血症诱导的动脉粥样硬化免疫代谢物
  • 批准号:
    10532799
  • 财政年份:
    2021
  • 资助金额:
    $ 37.87万
  • 项目类别:
A hypercholesterolemia-induced immunometabolite in atherosclerosis
高胆固醇血症诱导的动脉粥样硬化免疫代谢物
  • 批准号:
    10343505
  • 财政年份:
    2021
  • 资助金额:
    $ 37.87万
  • 项目类别:
PTN FUNCTION IN INTIMAL THICKENING
PTN 在内膜增厚中的作用
  • 批准号:
    8644302
  • 财政年份:
    2011
  • 资助金额:
    $ 37.87万
  • 项目类别:
PTN FUNCTION IN INTIMAL THICKENING
PTN 在内膜增厚中的作用
  • 批准号:
    8443877
  • 财政年份:
    2011
  • 资助金额:
    $ 37.87万
  • 项目类别:
PTN FUNCTION IN INTIMAL THICKENING
PTN 在内膜增厚中的作用
  • 批准号:
    8300899
  • 财政年份:
    2011
  • 资助金额:
    $ 37.87万
  • 项目类别:
PTN FUNCTION IN INTIMAL THICKENING
PTN 在内膜增厚中的作用
  • 批准号:
    8184098
  • 财政年份:
    2011
  • 资助金额:
    $ 37.87万
  • 项目类别:
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS
AAV 介导的 APO A1 基因治疗动脉粥样硬化
  • 批准号:
    6575135
  • 财政年份:
    2002
  • 资助金额:
    $ 37.87万
  • 项目类别:
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS
AAV 介导的 APO A1 基因治疗动脉粥样硬化
  • 批准号:
    6338900
  • 财政年份:
    2000
  • 资助金额:
    $ 37.87万
  • 项目类别:
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS
AAV 介导的 APO A1 基因治疗动脉粥样硬化
  • 批准号:
    6189142
  • 财政年份:
    1999
  • 资助金额:
    $ 37.87万
  • 项目类别:

相似海外基金

Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 37.87万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了